During the past decade, Southern Arizona Vascular Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Arizona Vascular Institute" #1 collaborator was "Southern Illinois University" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Southern Arizona Vascular Institute" are "Arterial Occlusive Diseases" (1 trials), "Carotid Artery Disease" (1 trials), "Critical Limb Ischemia" (1 trials), "Graft Occlusion, Vascular" (1 trials) and "Hyperplasia" (1 trials). Many other conditions were trialed in "Southern Arizona Vascular Institute" in a lesser frequency.

Most popular intervention types in "Southern Arizona Vascular Institute" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "CGT003 (E2F Duplex Decoy)" (1 trials), "Carotid WALLSTENT Monorail Endoprosthesis" (1 trials), "FilterWire EZ™ System™" (1 trials) and "UT-15C SR (treprostinil diethanolamine) 1mg oral tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern Arizona Vascular Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Southern Arizona Vascular Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Southern Arizona Vascular Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southern Arizona Vascular Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".